MERCK Stock Price
$47.155 
Change:
0.11 0.11% Volume:
1,462,241
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 47.155 | Todays Low: 46.61 | Open: 47.05 | Last Close: 47.355
52 Wk High: 48.785 | 52 Wk Low: 37.02 | Todays Pivot: 46.97 | Pre market open: 47.2
Sector: Healthcare and Pharmaceuticals
Merck Company Profile
Merck & Co (MRK) is a global pharmaceutical giant that manufactures key health products for human and animal health. They are the second largest company worldwide, as measured by market share. Grossing over $27 billion dollars annually, Merck are well known for producing leading scientific research and powerful pharmaceutical products. Since merging with Schering-Plough in 2009, the company has combined product lines for what they term is a “stronger pipeline”
» Read More About Merck
Related Healthcare and Pharmaceuticals Companies
Above is a small selection of related companies to Merck which compete alongside MRK within the Healthcare and Pharmaceuticals sector.
Online News For Merck
|
Billionaires Buy Merck Site to Build Swiss Biotech Campus - Science AAAS
Fri, 24 May 2013 16:30Swiss billionaires Hansjörg Wyss and Ernesto Bertarelli have bought the former building of drug company Merck Serono in Geneva, where they plan to set up a biotech research center with two local universities. The announcement, made on Wednesday, was ...
|
|
Merck loses round in Parkinson's fight - New York Business Journal
Sat, 25 May 2013 02:12Whitehouse Station, N.J.-based Merck (NYSE: MRK) said based on these results, it is taking steps to discontinue the extension phases of these studies and no longer plans to pursue regulatory filings for preladenant. The company added that the decision ...
|
|
FDA panel says Merck's sleep drug safe, effective at lower dose - Reuters
Wed, 22 May 2013 23:01WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug was safe and effective at the lower of two doses studied, a panel of medical experts said on Wednesday, increasing the chance it will be approved by the U.S. Food and Drug Administration.
|
|
Merck Insomnia Drug Safe Only in Lower Doses, Panel Says - Bloomberg
Wed, 22 May 2013 21:54Merck & Co. (MRK)'s experimental insomnia drug, meant to be a less disruptive alternative to Sanofi's Ambien sleeping pill, is safe only at lower doses, U.S. regulatory advisers said. Merck is seeking Food and Drug Administration approval to sell the ...
|
|
Merck Serono scouting biotech opportunities - Boston Globe
Fri, 24 May 2013 04:26Last week, Merck Serono said it was boosting its worldwide venture outlays from $51.4 million to $128.6 million, establishing a formal venture arm called MS Venture, and dispatching an executive to scout for potential portfolio companies in the Boston ...
|
|
Merck Announces $5 Billion Accelerated Share Repurchase - Business Wire (press release)
Thu, 23 May 2013 10:34WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it has entered into an accelerated share repurchase agreement (ASR) with Goldman, Sachs & Co. to ...
|
MRK Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Merck quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for MRK to choose from. Visit here to build your stock quote widget »